Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : MAP4343
Therapeutic Area : Psychiatry/Psychology
Study Phase : Phase II
Sponsor : Eurofins CDMO
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
March 12, 2019
Lead Product(s) : MAP4343
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase II
Sponsor : Eurofins CDMO
Deal Size : Inapplicable
Deal Type : Inapplicable